Literature DB >> 19406305

Pulmonary rehabilitation improves functional status in oncology patients.

G Stephen Morris1, Gail H Gallagher, Mary F Baxter, Kevin E Brueilly, Janet S Scheetz, Maaheen M Ahmed, Vickie R Shannon.   

Abstract

OBJECTIVE: To determine if participation in a pulmonary rehabilitation (PR) program improved the functional and physiologic status of oncology patients with chronic symptoms of shortness of breath, fatigue, and/or exercise intolerance.
DESIGN: Retrospective chart review.
SETTING: Comprehensive cancer center. PATIENTS: Oncology patients (N=30) (either a solid or a hematologic malignancy) with chronic dyspnea, exercise intolerance, and/or decreased functional status who had participated in an outpatient PR program.
INTERVENTIONS: The PR program used an individualized, progressive aerobic exercise program (2-3 sessions/wk for 8-12 weeks) that consisted of treadmill walking, riding on a bicycle ergometer and exercising on a sliding board. This program also included a didactic educational and psychosocial component. MAIN OUTCOME MEASURES: Functional status and exercise tolerance was assessed by the 6-minute walk test (6MWT) conducted at the beginning and end of the program. Self reports of perceived exertion and dyspnea were collected during and after these tests. Physiologic status was assessed by calculating 6-minute walk work (body mass x 6-minute walk distance).
RESULTS: Participation in the outpatient PR program significantly increased the 6-minute walk distance (21%, P<.05) and 6-minute walk work (17%, P<.05). Dyspnea and perceived exertion scores were similar at the pre- and postrehabilitation 6MWT despite the greater physiologic demand of the post-rehabilitation 6-minute walk. No adverse events occurred during the study.
CONCLUSIONS: The current study, although limited in size, suggests that participation in a comprehensive outpatient PR program is safe and of benefit in a heterogeneous population of oncology patients with pulmonary symptoms.

Entities:  

Mesh:

Year:  2009        PMID: 19406305     DOI: 10.1016/j.apmr.2008.12.005

Source DB:  PubMed          Journal:  Arch Phys Med Rehabil        ISSN: 0003-9993            Impact factor:   3.966


  7 in total

Review 1.  Dyspnea review for the palliative care professional: treatment goals and therapeutic options.

Authors:  Arif H Kamal; Jennifer M Maguire; Jane L Wheeler; David C Currow; Amy P Abernethy
Journal:  J Palliat Med       Date:  2012-01       Impact factor: 2.947

2.  Establishing a cancer nutrition rehabilitation program (CNRP) for ambulatory patients attending an Australian cancer center.

Authors:  Paul Glare; Wendy Jongs; Bill Zafiropoulos
Journal:  Support Care Cancer       Date:  2010-03-05       Impact factor: 3.603

3.  Fatigue and functional impairment in early-stage non-small cell lung cancer survivors.

Authors:  Robert Hung; Paul Krebs; Elliot J Coups; Marc B Feinstein; Bernard J Park; Jack Burkhalter; Jamie S Ostroff
Journal:  J Pain Symptom Manage       Date:  2011-01-08       Impact factor: 3.612

4.  Feasibility and effectiveness of a home-based exercise training program before lung resection surgery.

Authors:  Valerie Coats; François Maltais; Sébastien Simard; Eric Fréchette; Lise Tremblay; Fernanda Ribeiro; Didier Saey
Journal:  Can Respir J       Date:  2013 Mar-Apr       Impact factor: 2.409

5.  Cardiac Rehabilitation Programs for Cancer Survivors: A Scoping Review.

Authors:  Carmen C Cuthbertson; Emily E Pearce; Carmina G Valle; Kelly R Evenson
Journal:  Curr Epidemiol Rep       Date:  2020-05-08

6.  Understanding the importance of therapeutic relationships in the development of self-management behaviours during cancer rehabilitation: a qualitative research protocol.

Authors:  Wendy M Wilkinson; Jaynie Rance; Deborah Fitzsimmons
Journal:  BMJ Open       Date:  2017-01-17       Impact factor: 2.692

7.  Preoperative maximal voluntary ventilation, hemoglobin, albumin, lymphocytes and platelets predict postoperative survival in esophageal squamous cell carcinoma.

Authors:  Shou-Jia Hu; Xue-Ke Zhao; Xin Song; Ling-Ling Lei; Wen-Li Han; Rui-Hua Xu; Ran Wang; Fu-You Zhou; Liang Wang; Li-Dong Wang
Journal:  World J Gastroenterol       Date:  2021-01-28       Impact factor: 5.742

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.